Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Joint by Joint

Gretchen Henkel  |  Issue: November 2006  |  November 1, 2006

Dr. Sharp was also clear about one thing: Rheumatology “was a good field for somebody who was interested mostly in investigation.” When he began his rheumatology fellowship at Massachusetts General Hospital in 1953, the standard treatments for RA were aspirin (often to the point of toxicity), extra rest, and physical therapy. “There was so little that could be done for patients,” he recalls. “But in terms of opportunities for studies, it was fairly wide open.”

After his residency, Dr. Sharp took a position at Henry Ford Hospital in Detroit, Mich. The idea for an X-ray scoring system grew out of disagreements Dr. Sharp had with his colleagues there about whether gold was an appropriate treatment for RA. At the Massachusetts General Hospital, where he had trained, Walter Bauer, MD, and colleagues adamantly opposed gold therapy because of its serious toxicities. Dr. Sharp and his Ford Hospital colleagues were intrigued with a study in the early 1960s published by the British Empire Rheumatism Council showing symptomatic relief in patients given gold, but no benefit on the X-rays.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The rheumatologists at the Ford Hospital, including Dr. Sharp, felt that the study could be improved. The schedule of treatment in England differed from that at the Ford Hospital—stopping after a single course of injections, versus the American model of a loading dose followed by maintenance therapy. The team agreed that, to resolve the question, they should set up a two-year trial incorporating the latter schedule of treatments.

A Lone Voice

Dr. SharpNow retired, Dr. Sharp spends his days relaxing at his home on Bainbridge Island, although he remains active in the rheumatology community.
Now retired, Dr. Sharp spends his days relaxing at his home on Bainbridge Island, although he remains active in the rheumatology community.

If the team at Ford was to conduct its own study, Dr. Sharp insisted that the study should include good radiographic analysis. So, he accepted the challenge to establish that part. The X-ray analysis in the Rheumatism Council study only examined whether the investigators saw anything worse. “My thinking,” recalls Dr. Sharp, “was that if you assigned a number that was a reasonable estimate of ‘how much worse,’ that it might be sensitive enough to pick up the changes that you couldn’t see otherwise.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Joints in both feet and both hands were scored for erosions (from 0 to 5), and for joint space narrowing (from 0 to 4). Totals of all scores yielded the composite score.

The idea of using X-ray scoring was based on the realization that stored X-ray films were permanent records, says Dr. Sharp, who at the time had already instituted a routine of obtaining yearly hand X-rays of his patients. Swelling scores, in contrast, can differ from day to day, “and you can’t turn the patient back in time to check that score. But you can always get out the X-ray and review it.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Practice SupportProfilesResearch Rheum Tagged with:Clinical researchMetricsOutcome measuresRheumatoid Arthritis (RA)

Related Articles

    Remembrance of John Sharp, MD, Rheumatologist Extraordinaire

    December 1, 2008

    Dr. Sharp was a rheumatology pioneer who left a lasting mark on the field

    In the Lungs: Asthma & COPD May Be Early, Independent Risk Factors for RA

    June 1, 2020

    Recent research found women with COPD and asthma—even those who have never smoked—are at a higher risk of developing rheumatoid arthritis…

    The Great Debate: Should Jakinibs Be Used Before Biologics after Methotrexate Failure in RA?

    November 9, 2020

    ACR CONVERGENCE 2020—In many ways, the current plethora of treatment options for rheumatoid arthritis patients represents an embarrassment of riches. However, while many therapeutics approved by the U.S. Food & Drug Administration (FDA) are available, knowing the order in which to try these medications with patients can be quite challenging. In The Great Debate, held…

    Rheumatology’s Divergent Thinkers

    February 1, 2008

    OMERACT selects outcomes measures with an egalitarian process

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences